Growth Metrics

Hyperfine (HYPR) Accumulated Expenses (2020 - 2026)

Hyperfine posted quarterly Accumulated Expenses of $3.5 million for Q1 2026, up 266.6% year-on-year from $946000.0 in Q1 2025, and up 356.32% on a QoQ basis from $760000.0 in Q4 2025.

Hyperfine (HYPR) has 7 years of Accumulated Expenses data on file, last reported at $3.5 million in Q1 2026.

  • For the quarter ending Q1 2026, Accumulated Expenses rose 266.6% year-over-year to $3.5 million; the trailing twelve-month figure through Mar 2026 stood at $3.5 million (up 266.6% YoY), and the FY2025 full-year result was $760000.0, down 86.36% from the prior year.
  • Accumulated Expenses for Q1 2026 stood at $3.5 million, up from $760000.0 in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $6.0 million in Q4 2022 and bottomed at $661000.0 in Q2 2024.
  • The 5-year median for Accumulated Expenses is $1.3 million (2023), against an average of $2.4 million.
  • The widest annual swing landed in 2022, when Accumulated Expenses jumped 39633.87%; it then sank 86.36% in 2025.
  • A 5-year view of Accumulated Expenses shows it stood at $6.0 million in 2022, then dropped by 9.32% to $5.4 million in 2023, then advanced by 2.84% to $5.6 million in 2024, then tumbled by 86.36% to $760000.0 in 2025, then surged by 356.32% to $3.5 million in 2026.
  • The last three Accumulated Expenses figures came in at $3.5 million (Q1 2026), $760000.0 (Q4 2025), and $981000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Hyperfine 149.47 Mn 108.20 Mn 1.98 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 3.47 Mn
Dec 31, 2025 760,000.00
Sep 30, 2025 981,000.00
Jun 30, 2025 1.28 Mn
Mar 31, 2025 946,000.00
Dec 31, 2024 5.57 Mn
Sep 30, 2024 1.12 Mn
Jun 30, 2024 661,000.00
Mar 31, 2024 1.07 Mn
Dec 31, 2023 5.42 Mn
Sep 30, 2023 1.29 Mn
Jun 30, 2023 948,000.00
Mar 31, 2023 4.14 Mn
Dec 31, 2022 5.98 Mn
Sep 30, 2022 2.90 Mn
Jun 30, 2022 2.99 Mn
Mar 31, 2022 1.32 Mn
Dec 31, 2021 441,000.00
Sep 30, 2021 7,515.00
Jun 30, 2021 7,515.00
Mar 31, 2021 37,515.00
Dec 31, 2020 501,000.00